Return
TRIM72 alleviates skeletal muscle atrophy by modulating mt-dsRNA/RIG-I signaling
L
Z
W
J
S
X
Z
C
李
张
Y
K
J
R
H
X
M
G
DOI:10.1016/j.metabol.2026.156696.png)
Abstract
En 中文
• Cytosolic dsRNA links mitochondrial stress to muscle deterioration induced by aging, sciatic denervation and dexamethasone. • Mitochondrial dsRNA activates innate immune sensor RIG-I signaling and induces an inflammatory phenotype in myotubes. • TRIM72 interacts with RIG-I CARD domain to trigger its ubiquitination and degradation, as well as blocks leakage of mt-dsRNA. • Targeting mt-dsRNA/RIG-I signaling by recombinant TRIM72 supplementation is a potential therapeutic for muscle atrophy.
Journal
M
IF:
11.9
Papers:
9.6K
Citations:
2.1W
